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Abstract:  Purpose: To report a case of subretinal leakage after focal laser treatment for idiopathic central serous 
chorioretinopathy (ICSC). This rare complication was successfully treated with photodynamic therapy (PDT). 
Methods: Interventional case report. 
Results: A 36-year-old male presented with ICSC in his right eye. After a period of observation without resolution, he was 
treated with focal laser. That treatment resulted in a massive exacerbation of his subretinal fluid. PDT was successfully 
used to treat the severe exacerbation with rapid resolution of the subretinal fluid, improvement in visual acuity, decreased 
leakage on fluorescein angiography, and reduction of subretinal fluid on ophthalmoscopic exam and by optical coherence 
tomography. 
Conclusions: Ophthalmologists should consider the use of PDT in cases where focal laser causes an exacerbation of 
subretinal fluid in ICSC. 
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INTRODUCTION 
  Idiopathic central serous chorioretinopathy (ICSC) is a 
relatively common disorder of young or middle age indi-
viduals with abnormalities of the retinal pigment epithelium 
(RPE), resulting in focal areas of serous retinal detachment 
and pigment epithelial detachment [1]. Fluorescein 
angiography often demonstrates focal areas of leakage at the 
level of the RPE with pooling of dye into the subretinal or 
sub-pigment epithelial space. In most cases the leakage reso-
lves spontaneously with gradual return of good visual funct-
ion. If there is chronic or recurrent leakage treatment may be 
indicated. In such cases, light focal laser photocoagulation to 
the area of RPE abnormality and leakage may be employed 
[2-5]. 
  Here, we report a case of ICSC where focal laser photo-
coagulation resulted in a dramatic increase in fluid leakage 
with severe worsening of the serous macular detachment. 
Subsequent treatment with photodynamic therapy (PDT) 
resulted in prompt resolution of the leakage and reduction of 
subretinal fluid. 
CASE REPORT 
  A 36 year-old Caucasian male presented with two days of 
blurring of the central vision in the right eye with a best-
corrected visual acuity of 20/20-2. Four years ago, he had 
ICSC in the left eye that was successfully treated with 
reduced fluence PDT after an ineffective focal laser session. 
  Dilated fundus examination of the right eye disclosed an 
area of serous detachment in the superonasal macula   
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extending toward the center of the fovea (Fig. 1A). Optical 
coherence tomography (OCT) confirmed the presence of 
subretinal fluid in the superonasal macula just sparing the 
foveal center (Fig. 1B). Fluorescein angiography showed a 
focal spot of leakage at the level of the RPE in the 
superonasal macula with pooling of dye into the area of 
subretinal fluid seen on ophthalmoscopy (Figs. 1C, D). The 
fellow eye had a best-corrected visual acuity of 20/20 and 
dilated fundus examination revealed RPE hyperpigmentation 
in the inferior foveal region without subretinal fluid. 
  A diagnosis of recurrent ICSC was made and options for 
treatment were discussed including: observation, focal laser 
photocoagulation, or PDT. After an initial observation period 
of three months without symptomatic or funduscopic change, 
a decision was made to treat with focal laser 
photocoagulation. Twelve 200 μm light-intensity laser spots 
were applied with an argon laser to the area of leakage 
utilizing 200-400 mW at 100 msec duration. Ten days later 
the patient returned having noted a dramatic worsening of 
vision. At this point, the visual acuity in the right eye 
measured 20/400 without correction and improved to 20/150 
with a spherical correction of +0.75 diopters. 
  Repeat funduscopic examination disclosed a dramatic 
increase in subretinal fluid (Fig. 2A) that was confirmed by 
OCT (Fig. 2B). Fluorescein angiography showed a new area 
of leakage at the inferior edge of the laser scar (Figs. 2C, D). 
Because of the increased leakage a decision was made to 
treat with PDT. Verteporfin 6 mg/m
2 was administered 
intravenously and a 600 μm laser spot was applied to the 
area of leakage for 83 seconds at half-fluence. One week 
later visual acuity had improved to 20/60 without correction 
and the subretinal fluid had decreased in size both on exam 
and by OCT (Figs. 3A, B). Furthermore, there was no longer  
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Fig. (1). (A) Color fundus photograph of the right eye showing a well demarcated area of subretinal fluid in the superonasal macula. (B) 
Optical coherence tomography of the right eye showing subretinal fluid within the superior macula extending very close to the foveal center. 
(C) Early frame fluorescein angiogram of the right eye showing focal area of leakage in the superonasal macula. (D) Late frame fluorescein 
angiogram of the right eye showing increasing leakage with pooling into the area of subretinal fluid. 
 
Fig. (2). (A) Color fundus photograph and (B) optical coherence tomography of the right eye showing a dramatic increase in subretinal fluid 
after focal laser photocoagulation. (C) Early and (D) late frame fluorescein angiograms of the right eye showing a new area of leakage just 
below the area treated with laser photocoagulation with later leakage and pooling of dye. 8    The Open Ophthalmology Journal, 2011, Volume 5  Leng et al. 
leakage on fluorescein angiography (Figs. 3C,  D). At 3 
months after PDT visual acuity recovered to 20/20. 
Funduscopic exam and OCT showed no subretinal fluid and 
FA continued to show no leakage (Fig. 4). The patient 
continues to do well without further recurrence of leakage at 
after 12 months of follow up. 
DISCUSSION 
  Most cases of ICSC do not require any intervention and 
patients regain good visual function [1]. Treatment is 
indicated in patients with recurrent leakage because multiple 
episodes of leakage can result in permanently reduced 
vision. The most common intervention is focal laser 
photocoagulation, which has been shown to enhance the 
resolution of leakage and absorption of subretinal fluid; 
however, the mechanism of action is poorly understood. 
  PDT with verteporfin has also been utilized for treatment 
of some cases of ICSC [6-10]. Due to the fact that there is 
relatively little data on the safety and efficacy of PDT in 
patients with ICSC, this treatment is usually reserved for 
cases that have not resolved spontaneously and either are not 
candidates for focal laser (due to poorly defined leakage or 
leakage too close to the center of the fovea) or have failed 
treatment with focal laser. The mechanism by which PDT 
reduces leakage in ICSC is also poorly understood; however, 
it may help to decrease the choroidal hyperpermeability that 
is the proposed pathogenetic mechanism of this disease and 
can be observed during indocyanine green angiography [11]. 
  This case is unique in that focal laser photocoagulation 
resulted in no improvement in leakage four years prior in the 
patient’s left eye, and a dramatic worsening of leakage in the 
fellow eye described in this report. Focal laser treatment for 
ICSC has been reported to have some risk, including 
inadvertent treatment in the fovea and development of 
secondary choroidal neovascularization (CNV) at the laser 
scar [12, 13]. To the best of our knowledge the complication 
described here (dramatically increased subretinal fluid) has 
not been previously reported. It is highly unlikely that the 
increased fluid in our patient represented development of 
CNV because it occurred immediately after the laser 
treatment; however, it is unclear why laser treatment resulted 
in exacerbation of leakage. Fortunately, in both eyes of this 
patient, treatment with PDT resulted in rapid and complete 
resolution of macular leakage and serous detachment, 
although PDT has also been associated with the possible side 
effect of choroidal ischemia. 
  Most patients with ICSC never require intervention. In 
those that do require treatment focal laser photocoagulation 
will likely remain the most common treatment. However, 
PDT has been found to be effective in this disorder, and use 
of this treatment will likely increase. Specifically, one should 
consider the use of PDT in cases where there is increased 
leakage of subretinal fluid after focal laser treatment. 
Additionally, for patients with ICSC where focal laser was 
found to be unsuccessful in one eye, consideration should be 
given to using PDT as initial therapy if the fellow eye should 
it require treatment. 
 
Fig. (3). (A) Color fundus photograph and (B) optical coherence tomography of the right eye showing a reduction in the amount of subretinal 
fluid after PDT. (C) Early and (D) late frame fluorescein angiograms showing mild dye transmission in area treated by focal laser with late 
staining of the laser scar in the superonasal macula. PDT for ICSC Exacerbation  The Open Ophthalmology Journal, 2011, Volume 5    9 
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Fig. (4). (A) Color fundus photograph and (B) optical coherence tomography of the right eye showing complete resolution of subretinal fluid 
and a faint pigmented scar in the location of prior laser photocoagulation. (C) Early and (D) late frame fluorescein angiograms showing early 
hypofluorescence in the area of prior leakage and late staining of the laser scar with no leakage. 